Search results
23 sty 2024 · Smoking is by far the leading risk factor for lung cancer. About 80% of lung cancer deaths are thought to result from smoking, and this number is probably even higher for small cell lung cancer (SCLC).
- Lung Cancer Prevention
No matter what your age or how long you’ve smoked, quitting...
- About Us
Lung cancer (both small cell and non-small cell) is the...
- Malignant Mesothelioma
The American Cancer Society is a qualified 501(c)(3)...
- Causes, Risk Factors, and Prevention
Learn about the causes and risk factors for lung cancer and...
- E-cigarettes
American Cancer Society Guideline for Diet and Physical...
- Ways to Give
Cigarette smoking is by far the most common cause of lung...
- Arsenic
The American Cancer Society is a qualified 501(c)(3)...
- Secondhand Smoke
What is secondhand smoke? Secondhand smoke (SHS) is also...
- Lung Cancer Prevention
Read this short and simple guide about small cell lung cancer that covers diagnosis, treatment, questions to ask your doctor, and follow-up visits after treatment is complete. Downloadable PDFs About and Key Statistics [PDF]
14 gru 2017 · ASP8273 demonstrated antitumor activity in patients with EGFR-mutant lung cancers after prior treatment with EGFR TKIs. This study identified the ASP8273 RP2D to be 300 mg daily based on pharmacokinetics, pharmacodynamics, safety, and antitumor activity; the MTD was not established.
15 lut 2024 · Lung cancer screening rates have been and continue to be very low. A 2022 report by the American Lung Association showed that only 5.8% of eligible persons underwent lung cancer screening, with screening rates ranging from 1% in California to 16.3% (the highest rate) in Massachusetts. 4
1 lip 2019 · The current study examines the efficacy, safety, and tolerability of ASP8273 versus erlotinib or gefitinib in patients with non-small-cell lung cancer (NSCLC) with activating EGFR mutations not previously treated with an EGFR inhibitor.
1 lis 2023 · In this update of LCS, the ACS recommends that individuals aged 50–80 years who currently smoke or who formerly smoked and are at high risk for lung cancer because of a 20 or greater pack-year history of cigarette smoking undergo annual LCS with LDCT (Tables 1 and 2).
4 sie 2023 · Lung cancer screening has been demonstrated to reduce lung cancer mortality, but its benefits must be weighed against the potential harms of unnecessary procedures, false-positive radiological findings, and overdiagnosis. Individuals at highest risk of lung cancer are more likely to maximize benefits while minimizing harm from screening.
